These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 29268054)

  • 21. Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.
    Lek N; Acerini CL
    Curr Diabetes Rev; 2010 Jan; 6(1):9-16. PubMed ID: 20034372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of cystic fibrosis-related diabetes.
    Marshall BC; Butler SM; Stoddard M; Moran AM; Liou TG; Morgan WJ
    J Pediatr; 2005 May; 146(5):681-7. PubMed ID: 15870674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystic fibrosis related diabetes: Medical management.
    Ode KL; Chan CL; Granados A; Moheet A; Moran A; Brennan AL
    J Cyst Fibros; 2019 Oct; 18 Suppl 2():S10-S18. PubMed ID: 31679720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes mellitus in patients with cystic fibrosis.
    Alves Cde A; Aguiar RA; Alves AC; Santana MA
    J Bras Pneumol; 2007; 33(2):213-21. PubMed ID: 17724542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
    Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes.
    Moran A; Phillips J; Milla C
    Diabetes Care; 2001 Oct; 24(10):1706-10. PubMed ID: 11574430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystic fibrosis-related diabetes mellitus: etiology, evaluation, and management.
    Fischman D; Nookala VK
    Endocr Pract; 2008 Dec; 14(9):1169-79. PubMed ID: 19158056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glargine versus NPH insulin in cystic fibrosis related diabetes.
    Grover P; Thomas W; Moran A
    J Cyst Fibros; 2008 Mar; 7(2):134-6. PubMed ID: 17692577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effect of insulin treatment in cystic fibrosis-related diabetes.
    Mohan K; Israel KL; Miller H; Grainger R; Ledson MJ; Walshaw MJ
    Respiration; 2008; 76(2):181-6. PubMed ID: 17960051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin and oral agents for managing cystic fibrosis-related diabetes.
    Onady GM; Stolfi A
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004730. PubMed ID: 16034943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Automated glycemic control with the bionic pancreas in cystic fibrosis-related diabetes: A pilot study.
    Sherwood JS; Jafri RZ; Balliro CA; Zheng H; El-Khatib FH; Damiano ER; Russell SJ; Putman MS
    J Cyst Fibros; 2020 Jan; 19(1):159-161. PubMed ID: 31420176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canadian Cystic Fibrosis-related Diabetes Clinical Practice Survey: Analysis of Current Practices and Gaps in Clinical Care.
    Potter KJ; Coriati A; Hicks P; Lands LC; McKinney ML; Boudreau V; Bonhoure A; Luca P; Ho J; Tagougui S; Jober A; Pohl M; Rosolowsky ET; Gilmour J; Lam GY; Stephenson AL; Senior PA; Rabasa-Lhoret R; Kherani T
    Can J Diabetes; 2023 Apr; 47(3):263-271.e1. PubMed ID: 36872137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency?
    Dobson L; Sheldon CD; Hattersley AT
    J R Soc Med; 2004; 97 Suppl 44(Suppl 44):26-35. PubMed ID: 15239291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
    Bonhoure A; Potter KJ; Colomba J; Boudreau V; Bergeron C; Desjardins K; Carricart M; Tremblay F; Lavoie A; Rabasa-Lhoret R
    Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreasing the Time to Insulin Administration for Hospitalized Patients With Cystic Fibrosis-Related Diabetes.
    Smego A; Lawson S; Courter JD; Warden D; Corathers S
    Hosp Pediatr; 2018 May; 8(5):288-292. PubMed ID: 29691278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary interventions for managing glucose abnormalities in cystic fibrosis: a systematic review protocol.
    Birch L; Lithander FE; Hewer SL; Harriman K; Hamilton-Shield J; Perry R
    Syst Rev; 2018 Jul; 7(1):98. PubMed ID: 30021636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study.
    Bassi M; Franzone D; Dufour F; Spacco G; Cresta F; d'Annunzio G; Tantari G; Calevo MG; Castellani C; Minuto N; Casciaro R
    Front Endocrinol (Lausanne); 2024; 15():1347141. PubMed ID: 38966218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Consensus on the diagnosis and management of changes in carbohydrate metabolism in cystic fibrosis].
    Barrio Castellanos R ; Cos Blanco A ; García García E ; Gussinyé Cañadell M ; Merino Torres J ; Muñoz Calvo M
    An Esp Pediatr; 2000 Dec; 53(6):573-9. PubMed ID: 11148156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis.
    Granados A; Chan CL; Ode KL; Moheet A; Moran A; Holl R
    J Cyst Fibros; 2019 Oct; 18 Suppl 2():S3-S9. PubMed ID: 31679726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.
    Taylor-Cousar JL; Janssen JS; Wilson A; Clair CG; Pickard KM; Jones MC; Brayshaw SJ; Chacon CS; Barboa CM; Sontag MK; Accurso FJ; Nichols DP; Saavedra MT; Nick JA
    J Diabetes Res; 2016; 2016():1527932. PubMed ID: 27999822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.